Nutex Health (NASDAQ:NUTX) Stock Price Up 9.1% – What’s Next?

Nutex Health Inc. (NASDAQ:NUTXGet Free Report) traded up 9.1% during mid-day trading on Wednesday . The stock traded as high as $184.40 and last traded at $186.4720. 125,047 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 178,992 shares. The stock had previously closed at $170.89.

Wall Street Analyst Weigh In

NUTX has been the subject of a number of recent research reports. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. B. Riley Financial started coverage on Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 price target on the stock. Zacks Research upgraded Nutex Health to a “hold” rating in a research report on Monday. Finally, Lake Street Capital started coverage on Nutex Health in a report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price objective for the company. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Nutex Health presently has a consensus rating of “Moderate Buy” and an average target price of $243.33.

View Our Latest Stock Analysis on Nutex Health

Nutex Health Trading Up 11.1%

The company’s fifty day simple moving average is $131.86 and its two-hundred day simple moving average is $129.94. The company has a market capitalization of $1.31 billion, a price-to-earnings ratio of 14.67 and a beta of 0.26. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66.

Nutex Health (NASDAQ:NUTXGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. The business had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. Research analysts forecast that Nutex Health Inc. will post 22.72 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Nutex Health

Large investors have recently made changes to their positions in the stock. Islay Capital Management LLC bought a new stake in shares of Nutex Health in the fourth quarter valued at about $34,000. BNP Paribas Financial Markets raised its position in Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after buying an additional 290 shares during the last quarter. Royal Bank of Canada lifted its stake in Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after acquiring an additional 316 shares in the last quarter. Bank of America Corp DE lifted its stake in Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after acquiring an additional 2,043 shares in the last quarter. Finally, EverSource Wealth Advisors LLC acquired a new position in Nutex Health during the 1st quarter worth approximately $83,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Read More

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.